Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

This is a prospective, multi-center, randomized controlled trial to compare Billroth II reconstruction versus conventional Roux-en-Y reconstruction versus long limb Roux-en-Y reconstruction for glycemic control in patients with concurrent type 2 diabetes and gastric cancer.

Trial Details

NCT ID
NCT04284943
Phase
NA
Sponsor
Korea University Anam Hospital
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Long limb Roux-en-Y reconstruction after subtotal gastrectomy
  • Conventional Roux-en-Y reconstruction after subtotal gastrectomy
  • Billroth II reconstruction after subtotal gastrectomy
Locations (sample)
  • Seoul, South Korea|37.566,126.9784

Key Eligibility Criteria

  • Distal gastric adenocarcinoma diagnosed pathologically under preoperative endoscopic biopsy, and clinical stage I-II
  • Body mass index ≥ 23 kg/m2
  • Type 2 diabetes and HbA1c ≥ 6.5%

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →